Company: MDCXW
Filing Date: 2025-06-24
Form Type: 253G2
Source: 0001062993-25-012093
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-24
Form: 253G2
Chunk 3
---
Employment Agreement"). Pursuant to the terms of the Employment Agreement, Mr. Smith will commence employment as COO on or about June 30, 2025. In this role, Mr. Smith will receive an annual base salary of $325,000. Mr. Smith will also receive a grant of 100,000 stock options covering shares of the Company common stock with a strike price of $2.60 per share, vesting quarterly over the next five years, subject to Mr. Smith's continued service to the Company through each vesting date.

There are no family relationships between Mr. Smith and any director or executive officer of the Company pursuant to Item 401(d) of Regulation S-K and the Company has not entered into any transactions with Mr. Smith that are reportable pursuant to Item 404(a) of Regulation S-K. Except as described above, there are no arrangements or understandings between Mr. Smith and any other persons pursuant to which he will be appointed as an executive officer of the Company.

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

MEDICUS PHARMA LTD.

| By:    | /s/ Raza Bokhari                               |
| Name:  | Dr. Raza Bokhari                               |
| Title: | Executive Chairman and Chief Executive Officer |

Dated: June 23, 2025